弃分拆、换掌门!一家25年生物技术公司的“惊天变局”

生物制品圈
Yesterday

5月13日,比利时生物技术公司 Galapagos NV(Euronext & NASDAQ:GLPG)宣布有关拟议分离、执行领导层交接和董事会变动的最新战略更新。公司计划重新评估其先前提出的分离计划,并为其现有业务探索所有战略替代方案。作为战略更新的一部分,董事会已任命Henry Gosebruch为公司首席执行官兼董事会执行董事,接替Paul Stoffels,立即生效。公司董事会成员Jérô...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10